Checkmate Pharmaceuticals Inc

NASDAQ:CMPI   3:59:55 PM EDT
4.27
-0.12 (-2.73%)
Earnings Announcements

Checkmate Pharmaceuticals Announces Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/12/2021 21:07 GMT
Checkmate Pharmaceuticals Inc (CMPI) - Checkmate Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update.
Checkmate Pharmaceuticals Inc - Qtrly Loss per Share $0.88.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.75

More details on our Analysts Page.